{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=197364&min-AnswerDate=2018-11-26", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?identifier=197364&min-AnswerDate=2018-11-26", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=197364&min-AnswerDate=2018-11-26&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=197364&_page=0&min-AnswerDate=2018-11-26", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=197364&min-AnswerDate=2018-11-26", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=197364&min-AnswerDate=2018-11-26", "items" : [{"_about" : "http://data.parliament.uk/resources/1657695", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1657695/answer", "answerText" : {"_value" : "

The Foreign, Commonwealth and Development Office (FCDO) issued a formal apology to Mr Hedges on 31 August 2023 in accordance with the recommendations set out following an investigation by the Parliamentary and Health Service Ombudsman, which upheld aspects of his complaint. Supporting British nationals when they need help abroad remains an enduring priority of the FCDO.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4033", "label" : {"_value" : "Biography information for David Rutley"} } , "answeringMemberConstituency" : {"_value" : "Macclesfield"} , "answeringMemberPrinted" : {"_value" : "David Rutley"} , "dateOfAnswer" : {"_value" : "2023-09-07", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-07T15:51:44.117Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "208"} , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "date" : {"_value" : "2023-09-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Matthew Hedges"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, if he will make a formal apology to Matthew Hedges on the level of support offered by his Department while Mr Hedges was in prison in United Arab Emirates.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1409", "label" : {"_value" : "Biography information for Mr Gregory Campbell"} } , "tablingMemberConstituency" : {"_value" : "East Londonderry"} , "tablingMemberPrinted" : [{"_value" : "Mr Gregory Campbell"} ], "uin" : "197364"} , {"_about" : "http://data.parliament.uk/resources/1017183", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1017183/answer", "answerText" : {"_value" : "

The National Institute of Health and Care Excellence (NICE) is currently developing Technology appraisal guidance on the use of erenumab for preventing migraines. NHS commissioners are legally required to fund drugs and treatments recommended by NICE\u2019s technology appraisal programme. In the absence of positive guidance from NICE, it is for commissioners to make decisions on whether to fund this treatment based on an assessment of the available evidence.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-12-07", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-12-07T13:07:25.02Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-29", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Erenumab"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans the NHS has to make erenumab available to people with migraines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "197364"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }